N
STJ

Nuveen’s St Jude Medical STJ Stock Holding History

Nuveen’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-52,765
Closed -$4.23M – 1584
2016
Q4 		$4.23M Buy
52,765
+19,953
+61% +$1.58M 0.02% 664
2016
Q3 		$2.62M Buy
32,812
+1,413
+5% +$114K 0.02% 682
2016
Q2 		$2.45M Sell
31,399
-122
-0.4% -$8.7K 0.02% 674
2016
Q1 		$1.73K Sell
31,521
-4,626
-13% -$252K 0.01% 802
2015
Q4 		$2.23K Buy
36,147
+3,545
+11% +$224K 0.01% 729
2015
Q3 		$2.06K Sell
32,602
-6,359
-16% -$454K 0.01% 748
2015
Q2 		$2.85K Sell
38,961
-111,900
-74% -$8.08M 0.02% 678
2015
Q1 		$9.87M Buy
150,861
+61,797
+69% +$4.11M 0.05% 389
2014
Q4 		$5.79M Buy
89,064
+64,641
+265% +$4.16M 0.03% 508
2014
Q3 		$1.47M Buy
24,423
+2,266
+10% +$148K 0.01% 957
2014
Q2 		$1.53M Sell
22,157
-67,074
-75% -$4.35M 0.01% 934
2014
Q1 		$5.83M Sell
89,231
-98,213
-52% -$6.39M 0.04% 482
2013
Q4 		$11.6M Buy
187,444
+83,149
+80% +$4.81M 0.07% 327
2013
Q3 		$5.59M Sell
104,295
-4,579
-4% -$236K 0.04% 502
2013
Q2 		$4.97M Buy
+108,874
New +$4.72M 0.03% 520

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Nuveen's STJ Position: Q1 2017 in Review

Nuveen sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 52,765 shares — an estimated $4.23M sold.

Nuveen first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $11.6M in Q4 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Nuveen reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Nuveen sold 52,765 St Jude Medical shares in Q1 2017, an estimated $4.23M.
  • Nuveen first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Nuveen's St Jude Medical position peaked at $11.6M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Nuveen's 13F filing for Q1 2017, filed 15 May 2017.